files Class Action for Digitek Recall Patients.
On May 8, 2008, Malkinson &
Halpern, P.C. filed a federal class action lawsuit
in New Jersey on behalf of a Digitek patient,
and all others similarly situated in the United
The suit was filed two weeks after the U.S. Food
and Drug Administration (FDA) announced a complete
recall of Digitek, a widely used heart medication.
Digitek, manufactured by Actavis Totowa, is used
by millions of people to improve heart beat strength
or calm abnormal heart rhythms. The recall was
instituted because of a manufacturing issue that
had apparently resulted in tablets being distributed
for consumption that contained up to twice the
labeled dosage of the medicine.
Related Injuries. Excessive doses
can lead to digitalis toxicity, resulting in nausea,
vomiting, dizziness, low blood pressure, cardiac
instability, bradycardia, and even death. Digitalis
toxicity can also be associated with kidney failure.
Monetary Damages. Since the recall,
many users of the medication have also likely
undergone blood testing or other medical examinations
to evaluate the amount of digitalis in their system.
The lawsuit seeks damages to compensate users
who were injured by the recalled medication, and
Medical Monitoring to have the manufacturer compensate
patients for all incidental medical costs.
For a free claims evaluation, please contact
Malkinson & Halpern, P.C. if you or a
loved one were taking the recalled Digitek pursuant
to a prescription and have incurred expenses or
suffered injuries as a result.